Preliminary evaluation of magnetic resonance fresh blood imaging for diagnosis of Budd-Chiari syndrome

Chinese Medical Journal

Volumn 120, Issue 2, 2007, Pages 95-99

  Ren, Ke ^a   Xu, Ke ^a   Sun, Wen Ge ^a   Chen, Yu Shuai ^a   Qi, Xi Xun ^a   Li, Ran Liang ^a   Jin, An Yu ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Angiography; Budd Chiari syndrome; Fresh blood imaging; Hepatic vein thrombosis; Magnetic resonance

Indexed keywords

ARTICLE; BLOOD ANALYSIS; BUDD CHIARI SYNDROME; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC ERROR; DIAGNOSTIC PROCEDURE; DIAGNOSTIC VALUE; HUMAN; IMAGE ANALYSIS; INFERIOR CAVA VEIN OBSTRUCTION; INTERMETHOD COMPARISON; LIVER BLOOD FLOW; LIVER VEIN; MAGNETIC RESONANCE ANGIOGRAPHY; PREOPERATIVE EVALUATION; SENSITIVITY AND SPECIFICITY; SIGNAL DETECTION; THREE DIMENSIONAL IMAGING; THROMBOSIS; ULTRASOUND; AGED; FEMALE; INFERIOR CAVA VEIN; LIVER VEIN THROMBOSIS; MALE; METHODOLOGY; PATHOLOGY;

AGED; FEMALE; HEPATIC VEIN THROMBOSIS; HUMANS; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; VENA CAVA, INFERIOR;

EID: 33947492698     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00029330-200701020-00003     Document Type: Article

References (22)

1. Cazals-Hatem D, Vilgrain V, Genin P, Denninger MH, Durand F, Belghiti J, et al. Arterial and portal circulation and parenchymal changes in Budd-Chiari syndrome: A study in 17 explanted livers. Hepatology 2003; 37: 510-519.
2. Kamath PS. Budd-Chiari syndrome: Radiologic findings. Liver Transpl 2006; 12: 21-22.
3. Klein AS. Management of Budd-Chiari syndrome. Liver Transplantation 2006; 12 (11 Suppl 2):s23-s28.
4. Plessier A, Sibert A, Consigny Y, Hakime A, Zappa M, Denninger MH, et al. Aiming at minimal invasiveness as a therapeutic strategy for Budd-Chiari syndrome. Hepatology 2006; 44: 1308-1316.
5. Kubo T, Shibata T, Itoh K, Maetani Y, Isoda H, Hiraoka M, et al. Outcome of percutaneous transhepatic venoplasty for hepatic venous outflow obstruction after living donor liver transplantation. Radiology 2006; 239: 285-290.
6. Wang SL, Sze DY, Busque S, Razavi MK, Kee ST, Frisoli JK, et al. Treatment of hepatic venous outflow obstruction after piggyback liver transplantation. Radiology 2005; 236: 352-359.
7. Urata J, Miyazaki M, Wada H, Nakaura T, Yamashita Y, Takahashi M. Clinical evaluation of aortic diseases using nonenhanced MRA with ECG-triggered 3D half-Fourier FSE. J Magn Reson Imaging 2001; 14: 113-119.
8. Yokoyama K, Nitatori T, Inaoka S, Takahara T, Hachiya J. Non-contrast enhanced MR venography using 3D fresh blood imaging (FBI): initial experience. Radiat Med 2001; 19: 247-253.
9. Miyazaki M, Sugiura S, Tateishi F, Wada H, Kassai Y. Abe H. Non-contrast-enhanced MR angiography using 3D ECG-synchronized half-Fourier fast spin echo. J Magn Reson Imaging 2000; 12: 776-783.
10. Brancatelli G, Federle MP, Grazioli L, Golfieri R, Lencioni R. Benign regenerative nodules in Budd-Chiari syndrome and other vascular disorders of the liver: radiologic-pathologic and clinical correlation. Radiographics 2002; 22: 847-862.
11. Yang JY, Zhang L, Yu SP, Chen W, Zhuang WQ, Feng GS, et al. Reestablishment of second hepatic hilum: a new technique for the treatment of Budd-Chiari syndrome. Chin Med J. 2003; 116: 121-124.
12. Cheng LF, Wang ZQ, Li CZ, Cai FC, Linghu EQ, Mao YP, et al. Experience in sclerotherapy for esophagogastric variceal bleeding. Chin Med J 2002; 115: 919-922.
13. Lin J, Chen B, Wang JH. Diagnosis of systemic arterial diseases with whole-body 3D contrast-enhanced magnetic resonance angiography. Chin Med J. 2006; 119: 1772-1778.
14. Elsayes KM, Narra VR, Yin Y, Mukundan G, Lammle M, Brown JJ. Focal hepatic lesions: diagnostic value of enhancement pattern approach with contrast-enhanced 3D gradient-echo MR imaging. Radiographics 2005; 25: 1299-1320.
15. Gandini R, Konda D, Simonetti G. Transjugular intrahepatic portosystemic shunt patency and clinical outcome in patients with Budd-Chiari syndrome: covered versus uncovered stents. Radiology 2006; 241: 298-305.
16. Rossi P, Salvatori FM, Fanelli F, Bezzi M, Rossi M, Marcelli G, et al. Polytetrafluoroethylene-covered nitinol stent-graft for transjugular intrahepatic portosystemic shunt creation: 3-year experience. Radiology 2004; 231: 820-830.
17. Hussain HK, Syed I, Nghiem HV, Johnson TD, Carlos RC, Weadock WJ, et al. T2-weighted MR imaging in the assessment of cirrhotic liver. Radiology 2004; 230: 637-644.
18. Lau CT, Scott M, Stavropoulos SW, Soulen MC, Solomon JA, Clark TW. Dacron-covered stent-grafts in transjugular intrahepatic portosystemic shunts: initial experience. Radiology 2005; 236: 725-729.
19. Ko EY, Kim TY, Kim PN, Kim AY, Ha HK, Lee MG. Hepatic vein stenosis after living donor liver transplantation: evaluation with Doppler US. Radiology 2003; 229: 806-810.
20. Ferral H, Gamboa P, Postoak DW, Albernaz VS, Young CR, Speeg KV, et al. Survival after elective transjugular intrahepatic portosystemic shunt creation: prediction with model for end-stage liver disease score. Radiology 2004; 231: 231-236.
21. Washburn WK, Gish RG, Kamath PS. Model for end-stage liver disease (MELD) exception for Budd-Chiari syndrome. Liver Transpl 2006; 12: 93-94.
22. Semelka RC, Helmberger TKG. Contrast agents for MR imaging of the liver. Radiology 2001; 218: 27-38.